Uterine leiomyoma and adenomyosis
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. The patients had been diagnosed with uterus leiomyoma and adenomyosis by clinical symptoms, magnetic resonance imaging (MRI) and ultrasonography. 2. Blood routine: neutrophils (>1.5 *10^9/L), platelets (>100 *10^9/L) and hemoglobin (>90 g/L). 3. Have symptoms which related to uterine fibroids or adenomyosis, have the willings to receive this treatment. Leiomyomas: diameter >= 3cm and = 3cm and <= 10cm. 4. Ultrasound energy can spread completely.
Exclusion criteria
Exclusion criteria: 1. With the history of gynecologic malignant tumor. 2. Patients with connective tissue disorder or any foreign bodies in ultrasound energy channels. 3. Patients with bacterial vaginosis. 4. Pregnancy or desiring be pregnancy. 5. Has contraindication of MRI. 6. Central nervous system diseases, psychiatric disorders, unstable angina pectoris, congestive heart failure, severe arrhythmia and other serious uncontrollable diseases. 7. Any condition that may impair patient safety or integrity of research data, including serious medical risk factors, medical conditions, and laboratory abnormalities. 8. The patient is unwilling or unable to follow the research procedure, or may be separated from the observation for one course or more during the course of the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| volume of uterus;volume of leiomyomas;the thickness of endometrium measured by ultrasound;morphology of uterine cavity; | — |
Secondary
| Measure | Time frame |
|---|---|
| CA125;UFS-QOL;estrogen;progestin;follicle-stimulating hormone;androgen;prolactin;luteinizing hormone; | — |
Countries
China
Contacts
Beijing Friendship Hospital Affiliated to Capital Medical University